HomeNDC LookupIngredientsBisacodyl › 37808-0676-11
image loading
(from DailyMed)

Womens Laxative Bisacodyl 5 mg Tablet, Delayed Release

by H E B · 4 BLISTER PACK in 1 CARTON (37808-676-11) / 15 TABLET, DELAYED RELEASE in 1 BLISTER PACK
NDC 37808-0676-11
🏷️ FDA NDC (as labeled) 37808-676-11 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Discontinued by firm
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Jul 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

🆔 Identity & classification

FDA NDC (as labeled) 37808-676-11
Product NDC 37808-676
11-digit billing NDC 37808067611
RxCUI 308753
UNII 10X0709Y6I
UPC 0041220499892
Application # 505G(a)(3)
SPL Set ID 7a741a60-558b-4bdc-9e07-0bc572962163
Established class (EPC) Stimulant Laxative
Physiologic effect Increased Large Intestinal Motility; Stimulation Large Intestine Fluid/Electrolyte Secretion
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Jul 2026)
Marketing start 2015-09-16
Marketing end 2026-07-31
Route ORAL
Dosage form TABLET, DELAYED RELEASE
Substance BISACODYL
Why two NDCs? The FDA registers this code as 37808-676-11 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 37808-0676-11. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Stimulant Laxative class.

Pharmacologic class Stimulant Laxative
Drug family (ATC) Contact laxatives, Enemas
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerH E B
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code37808
First marketedSep 2015
Product typeHuman Otc Drug
Portfolio264 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • It depends on which form you're using. Oral tablets (like Dulcolax Stimulant Laxative) usually take 6 to 12 hours, so many people take them at bedtime and get results in the mornin...
  • No — it's really important not to chew, crush, or break bisacodyl tablets. They have a special protective coating that helps them reach the right part of your gut without irritatin...
  • Can I chew or crush the tablet if I have trouble swallowing?
  • Milk and antacids can break down the protective coating on bisacodyl tablets too soon, before the medicine reaches where it needs to work. This can cause stomach irritation and mak...
📖 Read our full Bisacodyl guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bisacodyl 5 mg 00904-6407-61 Major 10 tablets $0.046 Availability likely
Bisacodyl 5 mg 00904-6748-17 Major 25 tablets $0.046 Availability likely
Womens Gentle Laxative 5 mg 46122-0429-63 Amerisource 25 tablets $0.046 Availability likely
Gentle Laxative 5 mg 46122-0529-63 Amerisource 25 tablets $0.046 Availability likely
Gentle Laxative 5 mg 70000-0221-01 Cardinal 10 tablets $0.046 Availability likely
Gentle Laxative 5 mg 70000-0538-01 CARDINAL 100 tablets $0.046 Availability likely
Laxative 5 mg 70677-1086-01 Strategic 10 tablets $0.046 Availability likely
Gentle Laxative 5 mg 83324-0033-30 Chain 15 tablets $0.046 Availability likely
Laxative 5 mg 83324-0061-30 Chain 25 tablets $0.046 Availability likely
Fleet 5 mg 00132-0401-25 C.B. 25 tablets FDA listed
Gentle Laxative 5 mg 00363-0327-03 Walgreen 10 tablets FDA listed
Laxative 5 mg 00363-6760-01 Walgreen 15 tablets FDA listed
up and up gentle laxative 5 mg 11673-0116-25 Target 25 tablets FDA listed
Womens Gentle Laxative 5 mg 11673-0151-52 TARGET 25 tablets FDA listed
Bisacodyl 5 mg 11673-0182-52 TARGET 25 tablets FDA listed
laxative for women 5 mg 11822-0676-05 Rite 15 tablets FDA listed
Laxative 5 mg 11822-0790-01 Rite 25 tablets FDA listed
Gentle Laxative 5 mg 21130-0410-20 BETTER 200 tablets FDA listed
Womens Gentle Laxative 5 mg 21130-0555-30 BETTER 30 tablets FDA listed
Gentle Overnight Laxative 5 mg 21130-0827-06 Better 200 tablets Discontinued
Laxative Gentle 5 mg 30142-0827-12 Kroger 25 tablets FDA listed
Gentle Laxative 5 mg 36800-0327-03 Topco 10 tablets FDA listed
Gentle Laxative 5 mg 37808-0327-15 H 25 tablets FDA listed
Womens Laxative 5 mgthis 37808-0676-11 H 15 tablets Discontinued
Gentle Laxative 5 mg 37808-0680-11 H 15 tablets FDA listed
Laxative 5 mg 37835-0241-01 Bi-Mart 100 tablets FDA listed
Gentle Laxative 5 mg 37835-0244-30 Bi-Mart 15 tablets FDA listed
Gentle Laxative 5 mg 41163-0607-52 United 18 tablets FDA listed
Dulcolax Simulant Laxative 5 mg 41167-0101-00 Chattem, 8 tablets FDA listed
Dulcolax Stimulant Laxative 5 mg 41167-0200-01 Chattem, 10 tablets FDA listed
Dulcolax Pink Stimulant Laxative 5 mg 41167-0290-05 Chattem, 25 tablets FDA listed
Dulcolax Stimulant Laxative 5 mg 41167-0400-01 Chattem, 10 tablets FDA listed
Bisacodyl 5 mg 41226-0003-52 KROGER 25 tablets FDA listed
Womens Laxative 5 mg 41226-0151-52 KROGER 25 tablets FDA listed
gentle laxative 5 mg 41250-0339-56 Meijer 25 tablets FDA listed
Womens gentle laxative 5 mg 41250-0676-11 Meijer 15 tablets FDA listed
Publix Stimulant Laxative 5 mg 41415-0116-25 PUBLIX 25 tablets FDA listed
Publix Women Laxative 5 mg 41415-0121-30 PUBLIX 30 tablets FDA listed
Gentle Laxative 5 mg 46122-0767-11 Amerisource 25 tablets FDA listed
Gentle Laxative 5 mg 49035-0327-12 Wal-Mart 100 tablets FDA listed
Gentle Laxative 5 mg 49035-0706-12 Wal-Mart 100 tablets FDA listed
Stimulant Laxative 5 mg 49483-0003-00 TIME 100000 tablets FDA listed
Bisacodyl Laxative 5 mg 50804-0327-56 Geiss, 25 tablets FDA listed
Gentle Laxative 5 mg 50844-0327-15 L.N.K. 25 tablets FDA listed
Womens Gentle Laxative 5 mg 53943-0676-01 Discount 15 tablets FDA listed
Gentle Laxative 5 mg 53943-0677-01 Discount 15 tablets FDA listed
Bisacodyl 5 mg 55154-6897-00 Cardinal 1 tablet FDA listed
Laxative 5 mg 55319-0327-15 Family 25 tablets FDA listed
Gentle Laxative 5 mg 55319-0697-56 Family 25 tablets FDA listed
Laxomil 5 mg 55758-0504-01 Pharmadel 24 tablets FDA listed
Gentle Laxative 5 mg 55910-0327-62 DOLGENCORP, 15 tablets FDA listed
Laxative Gentle 5 mg 55910-0723-62 DOLGENCORP, 15 tablets FDA listed
Laxative 5 mg 55910-0792-56 DOLGENCORP, 25 tablets FDA listed
Extra Gentle Laxative 5 mg 55910-0954-52 DOLGENCORP 25 tablets FDA listed
laxative 5 mg 56062-0327-56 Publix 25 tablets FDA listed
Laxative 5 mg 56062-0976-01 Publix 15 tablets FDA listed
stimulant laxative enteric coated 5 mg 57896-0441-01 Geri-Care 100 tablets FDA listed
Gentle Laxative 5 mg 59779-0327-03 CVS 10 tablets FDA listed
C-Lax Laxative 5 mg 59779-0676-13 CVS 250 tablets FDA listed
Womens Gentle Laxative 5 mg 63868-0573-30 CHAIN 15 tablets FDA listed
Gentle Laxative Stimulant Laxative 5 mg 63868-0908-25 QUALITY 25 tablets FDA listed
Stimulant Laxative Enteric Coated 5 mg 66424-0002-01 SDA 100 tablets FDA listed
Laxative Gentle 5 mg 67091-0215-25 WinCo 25 tablets FDA listed
Laxative Women 5 mg 67091-0286-30 WinCo 15 tablets Discontinued
Laxative 5 mg 67091-0452-24 WinCo 15 tablets FDA listed
Bisacodyl 5 mg 68016-0688-10 Chain 100 tablets FDA listed
Bisacodyl Stimulant Laxative 5 mg 68163-0116-25 Raritan 25 tablets FDA listed
Womens Laxative 5 mg 68998-0398-85 Marc 25 tablets FDA listed
Laxative Enteric Coated 5 mg 68998-0404-92 Marc 25 tablets FDA listed
Bisacodyl 5mg 5 mg 69168-0398-92 Allegiant 25 tablets FDA listed
Laxative Enteric Coated 5 mg 69168-0404-03 Allegiant 250 tablets FDA listed
stimulant laxative 5 mg 69452-0541-83 BIONPHARMA 300 tablets FDA listed
Womens Gentle Laxative 5 mg 69842-0089-52 CVS 25 tablets FDA listed
Womens Laxative Enteric Coated 5 mg 70000-0570-01 CARDINAL 25 tablets FDA listed
GOOD REMEDIES GENTLE Laxative 5 mg 70692-0167-52 Strive 25 tablets FDA listed
RIGHT REMEDIES OVERNIGHT Laxative 5 mg 70692-0761-31 Strive 300 tablets FDA listed
stimulant laxative enteric coated 5 mg 71335-1531-00 Bryant 25 tablets FDA listed
Bisacodyl 5 mg 71335-2010-00 Bryant 25 tablets FDA listed
stimulant laxative enteric coated 5 mg 71610-0453-02 Aphena 2 tablets FDA listed
Bisacodyl 5 mg 71610-0700-02 Aphena 2 tablets FDA listed
Bisacodyl 5 mg 72090-0131-01 Pioneer 300 tablets FDA listed
Laxative 5 mg 76162-0676-01 TOPCO 15 tablets FDA listed
SIMPEX Bisacodyl laxative 5 mg 76457-0003-00 Simpex 100 tablets FDA listed
Gentle Laxative 5 mg 79903-0178-08 Wal-Mart 8 tablets FDA listed
Laxative 5 mg 80513-0409-20 Advanced 200 tablets FDA listed
Laxative 5 mg 83586-0116-01 HHH 100 tablets FDA listed
Bisacodyl 5 mg 84324-0132-01 NUVICARE 100 tablets FDA listed
stimulant laxative enteric coated 5 mg 85766-0148-00 Sportpharm 1000 tablets FDA listed
Laxative Enteric Coated 5 mg 85828-0404-92 Grocery 25 tablets FDA listed
Laxative 5 mg 79481-6760-01 Meijer 15 tablets FDA listed
Bisacodyl 5 mg 83586-0012-00 HHH 310000 tablets FDA listed
Stimulant Laxative Gentle 5 mg 51316-0327-03 CVS 10 tablets FDA listed
Gentle Laxative 5 mg 50804-0329-56 Geiss, 25 tablets FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2015
On the market since
Sep 2015
📍
2026
Currently FDA-listed
11 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Womens Laxative (this brand).

Top reported reactions

Constipation1,456
Nausea1,346
Pain1,088
Vomiting977
Fall825
Dyspnoea821
Pneumonia798

Age at onset

Neonate2
Child47
Adolescent30
Adult931
Elderly1,240

Reporter sex

12,870 reports
Male · 44%
Female · 56%
Unknown · 0%

Serious outcomes

Hospitalization6,846
Life-threatening1,053
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 1,143 447
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
37808-0676-11 You're viewing this 4 BLISTER PACK in 1 CARTON (37808-676-11) / 15 TABLET, DELAYED RELEASE in 1 BLISTER PACK 2015-09-16 Discontinued by firm

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 37808-676-11, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 37808-0676-11, written without dashes as 37808067611. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 37808-0676-11, the first segment (37808) is the labeler code FDA assigned to H E B; the middle segment (0676) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (11) identifies this exact package size and type. Together they name one specific package of one specific product.
Who lists this product with the FDA?
H E B is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 18 words

Uses for relief of occasional constipation (irregularity) this product generally produces bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 45 words

Directions take with a glass of water adults and children 12 years and over take 1 to 3 tablets in a single daily dose children 6 to under 12 years take 1 tablet in a single daily dose children under 6 years ask a doctor

⚠️ Warnings 138 words

Warnings Do not use if you cannot swallow without chewing. Ask a doctor before use if you have a sudden change in bowel habits that lasts more than 2 weeks stomach pain, nausea or vomiting When using this product do not chew or crush tablet(s) do not use within 1 hour after taking an antacid or milk you may have stomach discomfort, faintness and cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. you need to use a laxative for more than 1 week If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 39 words

Other information TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF) see end flap for expiration date and lot number avoid excessive humidity

🧪 Active Ingredient 9 words

Active ingredient (in each tablet) Bisacodyl USP, 5 mg

🧪 Inactive Ingredients 41 words

Inactive ingredients carmine, colloidal silicon dioxide, corn starch, FD&C red #40 aluminum lake, hypromellose, lactose anhydrous, magnesium stearate, methacrylic acid, microcrystalline cellulose, polydextrose, polyethylene glycol, shellac wax, simethicone, sodium bicarbonate, sodium lauryl sulfate, stearic acid, talc, titanium dioxide, triacetin, triethyl citrate

🎯 Purpose 3 words

Purpose Stimulant laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.